ID   DEGS2_RAT               Reviewed;         323 AA.
AC   Q564G3;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 1.
DT   29-MAY-2024, entry version 122.
DE   RecName: Full=Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2;
DE            EC=1.14.18.5;
DE            EC=1.14.19.17;
DE   AltName: Full=Degenerative spermatocyte homolog 2;
DE   AltName: Full=Sphingolipid 4-desaturase;
DE   AltName: Full=Sphingolipid C4-monooxygenase;
GN   Name=Degs2 {ECO:0000312|EMBL:AAH98701.1};
GN   Synonyms=Des2 {ECO:0000312|EMBL:CAI79417.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MYRISTOYLATION AT GLY-2.
RC   STRAIN=Sprague-Dawley {ECO:0000312|EMBL:CAI79417.1};
RC   TISSUE=Liver {ECO:0000269|PubMed:17716801};
RX   PubMed=17716801; DOI=10.1016/j.biochi.2007.07.001;
RA   Beauchamp E., Goenaga D., Le Bloc'h J., Catheline D., Legrand P., Rioux V.;
RT   "Myristic acid increases the activity of dihydroceramide delta4-desaturase
RT   1 through its N-terminal myristoylation.";
RL   Biochimie 89:1553-1561(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus {ECO:0000312|EMBL:AAH98701.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Bifunctional enzyme which acts both as a sphingolipid
CC       delta(4)-desaturase and a sphingolipid C4-monooxygenase.
CC       {ECO:0000250|UniProtKB:Q8R2F2}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a dihydroceramide + 2 Fe(II)-[cytochrome b5] + 2 H(+) + O2 = a
CC         phytoceramide + 2 Fe(III)-[cytochrome b5] + H2O;
CC         Xref=Rhea:RHEA:55808, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:139048,
CC         ChEBI:CHEBI:139051; EC=1.14.18.5;
CC         Evidence={ECO:0000250|UniProtKB:Q8R2F2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylsphinganine + 2 Fe(II)-[cytochrome b5] + 2 H(+) + O2
CC         = an N-acylsphing-4-enine + 2 Fe(III)-[cytochrome b5] + 2 H2O;
CC         Xref=Rhea:RHEA:46544, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:31488,
CC         ChEBI:CHEBI:52639; EC=1.14.19.17;
CC         Evidence={ECO:0000250|UniProtKB:Q8R2F2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 Fe(II)-[cytochrome b5] + 2 H(+) + N-octanoylsphinganine + O2
CC         = 2 Fe(III)-[cytochrome b5] + H2O + N-octanoyl-4-hydroxysphinganine;
CC         Xref=Rhea:RHEA:43116, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:82841,
CC         ChEBI:CHEBI:82842; Evidence={ECO:0000250|UniProtKB:Q6QHC5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43117;
CC         Evidence={ECO:0000250|UniProtKB:Q6QHC5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylsphinganine + 2 Fe(II)-[cytochrome b5] + 2 H(+) + O2
CC         = an N-acyl-(4R)-4-hydroxysphinganine + 2 Fe(III)-[cytochrome b5] +
CC         H2O; Xref=Rhea:RHEA:46364, Rhea:RHEA-COMP:10438, Rhea:RHEA-
CC         COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:31488,
CC         ChEBI:CHEBI:31998; EC=1.14.18.5;
CC         Evidence={ECO:0000250|UniProtKB:Q6QHC5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46365;
CC         Evidence={ECO:0000250|UniProtKB:Q6QHC5};
CC   -!- PATHWAY: Membrane lipid metabolism; sphingolipid biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q8R2F2}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8R2F2}.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family. DEGS
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ938082; CAI79417.1; -; mRNA.
DR   EMBL; BC098701; AAH98701.1; -; mRNA.
DR   RefSeq; NP_001017457.1; NM_001017457.2.
DR   AlphaFoldDB; Q564G3; -.
DR   STRING; 10116.ENSRNOP00000015855; -.
DR   iPTMnet; Q564G3; -.
DR   PhosphoSitePlus; Q564G3; -.
DR   PaxDb; 10116-ENSRNOP00000015855; -.
DR   Ensembl; ENSRNOT00000015855.7; ENSRNOP00000015855.4; ENSRNOG00000011716.7.
DR   Ensembl; ENSRNOT00055054157; ENSRNOP00055044791; ENSRNOG00055031270.
DR   Ensembl; ENSRNOT00060043600; ENSRNOP00060036147; ENSRNOG00060025186.
DR   Ensembl; ENSRNOT00065042905; ENSRNOP00065035110; ENSRNOG00065024979.
DR   GeneID; 314438; -.
DR   KEGG; rno:314438; -.
DR   UCSC; RGD:1305023; rat.
DR   AGR; RGD:1305023; -.
DR   CTD; 123099; -.
DR   RGD; 1305023; Degs2.
DR   eggNOG; KOG2987; Eukaryota.
DR   GeneTree; ENSGT00390000013448; -.
DR   HOGENOM; CLU_032156_0_0_1; -.
DR   InParanoid; Q564G3; -.
DR   OMA; FEWVYND; -.
DR   OrthoDB; 5485164at2759; -.
DR   PhylomeDB; Q564G3; -.
DR   TreeFam; TF313582; -.
DR   BRENDA; 1.14.19.17; 5301.
DR   Reactome; R-RNO-1660661; Sphingolipid de novo biosynthesis.
DR   SABIO-RK; Q564G3; -.
DR   UniPathway; UPA00786; -.
DR   PRO; PR:Q564G3; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000011716; Expressed in duodenum and 18 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0102772; F:sphingolipid C4-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042284; F:sphingolipid delta-4 desaturase activity; ISO:RGD.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006667; P:sphinganine metabolic process; ISO:RGD.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; ISO:RGD.
DR   CDD; cd03508; Delta4-sphingolipid-FADS-like; 1.
DR   InterPro; IPR011388; DES1/DES2.
DR   InterPro; IPR005804; FA_desaturase_dom.
DR   InterPro; IPR013866; Sphingolipid_d4-desaturase_N.
DR   PANTHER; PTHR12879; SPHINGOLIPID DELTA 4 DESATURASE/C-4 HYDROXYLASE PROTEIN DES2; 1.
DR   PANTHER; PTHR12879:SF21; SPHINGOLIPID DELTA(4)-DESATURASE_C4-MONOOXYGENASE DES2; 1.
DR   Pfam; PF00487; FA_desaturase; 1.
DR   Pfam; PF08557; Lipid_DES; 1.
DR   PIRSF; PIRSF017228; Sphnglp_dlt4_des; 1.
DR   SMART; SM01269; Lipid_DES; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; Lipoprotein;
KW   Membrane; Myristate; Oxidoreductase; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:17716801"
FT   CHAIN           2..323
FT                   /note="Sphingolipid delta(4)-desaturase/C4-monooxygenase
FT                   DES2"
FT                   /evidence="ECO:0000269|PubMed:17716801"
FT                   /id="PRO_0000312818"
FT   TRANSMEM        41..61
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        68..88
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        200..220
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          95..99
FT                   /note="Required for C4-hydroxylase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R2F2"
FT   MOTIF           89..93
FT                   /note="Histidine box-1"
FT                   /evidence="ECO:0000305"
FT   MOTIF           128..132
FT                   /note="Histidine box-2"
FT                   /evidence="ECO:0000305"
FT   MOTIF           259..263
FT                   /note="Histidine box-3"
FT                   /evidence="ECO:0000305"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:17716801"
SQ   SEQUENCE   323 AA;  37441 MW;  FCB8061A3CDB7683 CRC64;
     MGNSAARSDF EWVYSDQPHT QRRKEMLAKY PSIKALMRPD PNIKWTVLGM VLVQVLACWL
     VRGLSWRWLL FWAYAFGGCI NHSLTLAIHD ISHNTAFGTR CASRNRWFAV FANLPIGLPY
     ATSFKKYHVD HHRYLGGDGL DVDIPTDFEG WFFCTPARKL LWLVLQPFFY SLRPLYVNPK
     AVTRMEILNA LVQLAFNVTI FALWGIKAIV YLLASSLLGL GLHPISGHFV AEHYMFLKGH
     ETYSYYGPLN WITFNVGYHV EHHDFPSIPG CYLPLVRMIA PEYYDHLPQH HSWVKVLWDF
     VFEDSLGPYS RVKRKCKLAK DQL
//
